Recent research suggests that acid reflux medications could potentially trigger migraines. Scientists have identified a higher risk of experiencing severe headaches among individuals who use acid-reducing drugs such as proton pump inhibitors (PPIs) like omeprazole and esomeprazole, histamine H2-receptor antagonists (H2 blockers) such as cimetidine and famotidine, and antacid supplements.
Although the study revealed an association between acid-reducing drugs and migraines, it does not definitively prove causation. Acid reflux occurs when stomach acid moves into the esophagus, typically after eating or while lying down.
Those with acid reflux may suffer from heartburn and ulcers, and prolonged acid reflux may lead to gastroesophageal reflux disease (GERD), which can increase the risk of esophageal cancer. Professor Margaret Slavin from the University of Maryland emphasized the need for further investigation due to the widespread use of acid-reducing drugs and their potential connection to migraines.
The study, which analyzed data from over 11,800 participants reporting their use of prescribed acid-reducing medications and migraine or severe headache occurrences in the past three months, found that individuals taking PPIs had a 25% incidence of migraines or severe headaches compared to 19% among non-users. Similarly, 25% of those using H2 blockers and 22% of those using antacid supplements experienced severe headaches, higher than the respective percentages of non-users.
After adjusting for various factors like age, sex, caffeine, and alcohol consumption, researchers observed a 70% increased likelihood of migraines in PPI users, a 40% higher risk in H2 blocker users, and a 30% elevated risk in antacid supplement users. The findings were published in the journal Neurology Clinical Practice.
Professor Slavin emphasized the necessity for individuals with acid reflux or other conditions requiring acid-reducing medications to consult their healthcare providers regarding the continuation of their treatment if they experience migraines or severe headaches.
While previous studies have indicated a potential link between gastrointestinal issues and migraines, the study’s findings regarding acid-reducing drugs and migraines suggest a more complex relationship that requires further exploration.